GlassScriptPhysician profile
Laina D Leboeuf
NPI 1053542951
$1,181.01
in general payments reported to CMS, 2019-2025
10 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.36 · 2022: $223 · 2023: $243 · 2024: $511 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $362.59 | 2021-2025 | Collagenase Santyl, Grafix, Stravix |
| Organogenesis INC. | $227.51 | 2021-2024 | Puraply |
| Convatec INC. | $221.01 | 2021-2025 | |
| Imperative Care, INC | $136.58 | 2023 | Symphony Catheter |
| Hydrofera LLC | $136.04 | 2024 | Hydrofera Blue |
| Abbvie INC. | $29.03 | 2023 | |
| Solventum Corporation | $20.05 | 2024 | Activ.A.C. |
| Hartmann USA, INC. | $17.77 | 2024 | Colactive Plus 2x2 |
| Kci USA, INC. | $15.49 | 2023 | 3m Cavilon, Promogran Prisma, Activ.A.C. |
| Urgo Medical North America, LLC | $14.94 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laina Leboeuf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.